Evidence-based Colloid Use in the Critically Ill
- 1 December 2004
- journal article
- review article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 170 (11) , 1247-1259
- https://doi.org/10.1164/rccm.200208-909st
Abstract
No abstract availableThis publication has 210 references indexed in Scilit:
- Twenty-five percent albumin prevents lung injury following shock/resuscitationCritical Care Medicine, 2003
- Hypoproteinemia predicts acute respiratory distress syndrome development, weight gain, and death in patients with sepsisCritical Care Medicine, 2000
- Comparison of three plasma expanders used as priming fluids in cardiopulmonary bypass patientsPerfusion, 1998
- A Comparison of 10% Pentastarch and 5% Albumin in Patients Undergoing Open‐Heart SurgeryThe Journal of Clinical Pharmacology, 1994
- Total therapeutic paracentesis (TTP) with and without intravenous albumin in the treatment of cirrhotic tense ascites: a randomized controlled trialLiver International, 1993
- Hydroxyethyl starch: an alternative to plasma for postoperative volume expansion after cardiac surgeryBritish Journal of Surgery, 1988
- Hydroxyethyl Starch versus Albumin for Colloid Infusion Following Cardiopulmonary Bypass in Patients Undergoing Myocardial RevascularizationThe Annals of Thoracic Surgery, 1984
- Clinical Comparison of Hetastarch and Albumin in Postoperative Cardiac PatientsThe Annals of Thoracic Surgery, 1982
- Pulmonary edema during volume infusion.Circulation, 1975
- Pulmonary edema related to changes in colloid osmotic and pulmonary artery wedge pressure in patients after acute myocardial infarction.Circulation, 1975